Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study
- PMID: 31029178
- PMCID: PMC6486973
- DOI: 10.1186/s40360-019-0297-7
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study
Abstract
Background: Adverse drug events (ADEs) are a significant cause of emergency department (ED) visits, with a major impact on healthcare resource utilization. A multicentre observational study, aimed to describe frequency, seriousness and preventability of ADEs reported in four EDs, was performed in Sicily (Italy) over a 1-year period.
Methods: Two trained monitors for each ED supported clinicians in identifying ADEs of patients admitted to EDs between June 1st, 2013 and May 31st, 2014 through a systematic interview of patients or their caregivers and with an additional record review. A research team analyzed each case of suspected ADE, to make a causality assessment applying the Naranjo algorithm and a preventability assessment using Schumock and Thornton criteria. Absolute and percentage frequencies with 95% confidence interval (CI) and medians with interquartile ranges (IQR) were estimated. Logistic regression models were used to evaluate independent predictors of serious and certainly preventable ADEs.
Results: Out of 16,963 ED visits, 575 (3.4%) were associated to ADEs, of which 15.1% resulted in hospitalization. ADEs were classified as probable in 45.9%, possible in 51.7% and definite in 2.4% of the cases. Moreover, ADEs were considered certainly preventable in 12.3%, probably preventable in 58.4%, and not preventable in 29.2% of the cases. Polytherapy influenced the risk to experience a serious, as well as a certainly preventable ADE. Whilst, older age resulted an independent predictor only of serious events. The most common implicated drug classes were antibiotics (34.4%) and anti-inflammatory drugs (22.6%). ADEs due to psycholeptics and antiepileptics resulted preventable in 62.7 and 54.5% of the cases, respectively. Allergic reactions (64%) were the most frequent cause of ADE-related ED visits, followed by neurological effects (10.2%) that resulted preventable in 1.9 and 37.3% of the cases, respectively.
Conclusion: ADEs are a frequent cause of ED visits. The commonly used antibiotics and anti-inflammatory drugs should be carefully managed, as they are widely involved in mild to severe ADEs. Polytherapy is associated with the occurrence of serious, as well as certainly preventable ADEs, while older age only with serious events. A greater sensitivity to drug monitoring programs among health professionals is needed.
Keywords: Adverse drug event; Causality; Emergency department; Preventability; Seriousness.
Conflict of interest statement
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.PLoS One. 2018 Jun 27;13(6):e0199456. doi: 10.1371/journal.pone.0199456. eCollection 2018. PLoS One. 2018. PMID: 29949616 Free PMC article.
-
Comparing characteristics of adverse drug events between older and younger adults presenting to a Taiwan emergency department.Medicine (Baltimore). 2015 Feb;94(7):e547. doi: 10.1097/MD.0000000000000547. Medicine (Baltimore). 2015. PMID: 25700322 Free PMC article.
-
Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).Front Pharmacol. 2020 Apr 6;11:412. doi: 10.3389/fphar.2020.00412. eCollection 2020. Front Pharmacol. 2020. PMID: 32327995 Free PMC article.
-
[Adverse drug events of older patients presenting in the emergency department].Ther Umsch. 2015 Dec;72(11-12):673-7. doi: 10.1024/0040-5930/a000736. Ther Umsch. 2015. PMID: 26654810 Review. German.
-
Prevalence of adverse drug events and adverse drug reactions in hospital among older patients with dementia: A systematic review.Br J Clin Pharmacol. 2021 Feb;87(2):375-385. doi: 10.1111/bcp.14417. Epub 2020 Jul 6. Br J Clin Pharmacol. 2021. PMID: 32520427
Cited by
-
Health professionals' experience and perceived obstacles with managing patients' medication information in Norway: cross-sectional survey.BMC Health Serv Res. 2024 Jan 13;24(1):68. doi: 10.1186/s12913-023-10485-9. BMC Health Serv Res. 2024. PMID: 38218841 Free PMC article.
-
Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.Drug Saf. 2023 Nov;46(11):1161-1172. doi: 10.1007/s40264-023-01348-7. Epub 2023 Oct 2. Drug Saf. 2023. PMID: 37783974 Free PMC article.
-
Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database.Pharmaceuticals (Basel). 2023 Aug 15;16(8):1161. doi: 10.3390/ph16081161. Pharmaceuticals (Basel). 2023. PMID: 37631076 Free PMC article.
-
Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population.Int J Clin Pharm. 2024 Dec;46(6):1327-1334. doi: 10.1007/s11096-024-01760-8. Epub 2024 Jul 3. Int J Clin Pharm. 2024. PMID: 38958864 Free PMC article.
-
Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review.Eur J Clin Pharmacol. 2021 Oct;77(10):1443-1452. doi: 10.1007/s00228-021-03131-y. Epub 2021 Apr 7. Eur J Clin Pharmacol. 2021. PMID: 33829295 Review.
References
-
- Rodríguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21:623–650. - PubMed
-
- Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. Ann Emerg Med. 2005;45:197–206. - PubMed
-
- Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54:959–963. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical